Although the scientific relevance on the aforementioned cardiovascular danger factor alterations by tirzepatide is going to be assessed within the prepared cardiovascular outcome review SURPASS-CVOT ( "variety":"clinical-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-analysis indicated that tirzepatide did not ... https://bathsalts93639.dbblog.net/1319418/article-under-review